Self‐reported pain · children aged 3‐16 years with chronic illness (cancer) or generally healthy undergoing bone marrow aspirations, lumbar punctures,…
1 finding from 1 review
Self‐reported distress · children aged 3‐16 years with chronic illness (cancer) or generally healthy undergoing bone marrow aspirations, lumbar punctures,…
1 finding from 1 review
Observer‐reported pain · children aged 3‐16 years with chronic illness (cancer) or generally healthy undergoing bone marrow aspirations, lumbar punctures,…
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Observer‐reported distress · children aged 3‐16 years with chronic illness (cancer) or generally healthy undergoing bone marrow aspirations, lumbar punctures,…
1 finding from 1 review
Behavioral measures‐ pain · children aged 3‐16 years with chronic illness (cancer) or generally healthy undergoing bone marrow aspirations, lumbar punctures,…
1 finding from 1 review
Behavioral measures‐ distress · children aged 3‐16 years with chronic illness (cancer) or generally healthy undergoing bone marrow aspirations, lumbar punctures,…
1 finding from 1 review
Self‐reported distress · children aged 2‐19 years with mixed medical (acute or chronic illness) or generally healthy undergoing venipuncture, immunization,…
1 finding from 1 review
Observer‐reported pain · children aged 2‐19 years with mixed medical (acute or chronic illness) or generally healthy undergoing venipuncture, immunization,…
1 finding from 1 review
Observer‐reported distress · children aged 2‐19 years with mixed medical (acute or chronic illness) or generally healthy undergoing venipuncture, immunization,…
1 finding from 1 review
Behavioral measures‐ pain · children aged 2‐19 years with mixed medical (acute or chronic illness) or generally healthy undergoing venipuncture, immunization,…
1 finding from 1 review
Behavioral measures‐ distress · children aged 2‐19 years with mixed medical (acute or chronic illness) or generally healthy undergoing venipuncture, immunization,…
1 finding from 1 review
Self‐reported pain · children aged 3‐18 years with mixed medical (acute or chronic illness) or generally healthy undergoing immunization, intravenous…
1 finding from 1 review
Self‐reported distress · children aged 3‐18 years with mixed medical (acute or chronic illness) or generally healthy undergoing immunization, intravenous…
1 finding from 1 review
Observer‐reported pain · children aged 3‐18 years with mixed medical (acute or chronic illness) or generally healthy undergoing immunization, intravenous…
1 finding from 1 review
Mortality attributable to hepatic veno‐occlusive disease ( · People undergoing autologous or HLA identical allogeneic bone marrow transplant with a variety of malignant diseases or aplastic anaemia
Summary of findings: Heparin showed no clear difference in mortality attributable to hepatic veno‐occlusive disease ( compared with no treatment (low certainty).
1 finding from 1 review
Quality of life · People undergoing autologous or HLA identical allogeneic bone marrow transplant with a variety of malignant diseases or aplastic anaemia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Frequency of adverse events ( · People undergoing autologous or HLA identical allogeneic bone marrow transplant with a variety of malignant diseases or aplastic anaemia
It is very uncertain whether summary of findings: Heparin changes frequency of adverse events ( compared with no treatment (very low certainty).
1 finding from 1 review
Incidence of hepatic veno‐occlusive disease ( · People undergoing autologous or HLA identical allogeneic bone marrow transplant with a variety of malignant diseases or aplastic anaemia
It is very uncertain whether summary of findings: Heparin changes incidence of hepatic veno‐occlusive disease ( compared with no treatment (very low certainty).
1 finding from 1 review
Overall survival ( · People undergoing autologous or HLA identical allogeneic bone marrow transplant with a variety of malignant diseases or aplastic anaemia
It is very uncertain whether summary of findings: Heparin changes overall survival ( compared with no treatment (very low certainty).
1 finding from 1 review
All‐cause mortality at 100 days post‐transplant · People undergoing autologous or HLA identical allogeneic bone marrow transplant with a variety of malignant diseases or aplastic anaemia
Summary of findings: Heparin showed no clear difference in all‐cause mortality at 100 days post‐transplant ( compared with no treatment (low certainty).
1 finding from 1 review